Donato Brian Di

Chief Financial Officer, ACHILLION PHARMACEUTICALS INC.

Companies

ImmunocoreChief financial officer Jan 2, 2024 to Feb 21, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Immunocore IMCR19,230 shares²$573.2K at $29.81Jan 2, 2024

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARImmunocore, Chief financial officer
2
SEC EDGARImmunocore shares after the filing of Jan 2, 2024